U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07398404) titled 'A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients' on Jan. 28.
Brief Summary: The purpose of this research study is to evaluate a multiple health behavior change intervention for weight loss and smoking cessation using medication (Naltrexone + Bupropion) and behavior therapy in adults seeking bariatric surgery. The intervention will be compared to a standard of care control group.
Study Start Date: July 01, 2026
Study Type: INTERVENTIONAL
Condition:
Obesity
Smoking Cessation
Bariatric Surgery Patients
Intervention:
DRUG: Naltrexone hydrochloride
Part...